Genentech, Boehringer Ingelheim sales and marketing update

DNA partner Boehringer launched in Germany, the Netherlands, Sweden, Austria, Denmark and Finland DNA's Metalyse tenecteplase single bolus thrombolytic agent to treat acute myocardial infarction (AMI...